Stephen Robert Young

This inventor holds 19 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Kinase Inhibitors. Top assignees: Vertex Pharmaceuticals, Inc., Oxford Nanopore Technologies Limited, Other. Active years: 2012-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen Robert Young. Retrieved from https://idiyas.com/inventor/stephen-robert-young

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 8)

% Patents Active = 52.6

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 9)

Average Co-Inventor Count = 7.9

ph-index = 9

Forward Citations = 218(Granted Patents)

Location History:

Abingdon, GB (2013 - 2015)
Oxford, GB (2012 - 2024)

Company Filing History:

15 out of 1,168

Vertex Pharmaceuticals, Inc.

patents

3 out of 211

Oxford Nanopore Technologies Limited

patents

1 out of 834,570

Other

patents

Years Active: 2012-2025

Loading Chart...

Areas of Expertise:

Kinase Inhibitors

Pyrazines

Pyridines

Aminopyridine

Indoleamine

ATR Kinase

Tri-Cyclic

Amino Substituted

Pyrazolopyridine

Substituted Pyrazines

Aminopyrimidines

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12371458 - Mutant pore (2025-07-29),

2. 11939359 - Mutant pore (2024-03-26),

3. 11104709 - Mutant pore (2021-08-31),

4. 10961232 - Substituted pyrazines as ATR kinase inhibitors (2021-03-30),

5. 9701674 - Substituted pyrazines as ATR kinase inhibitors (2017-07-11),

6. 9499497 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase (2016-11-22),

7. 9365557 - Substituted pyrazin-2-amines as inhibitors of ATR kinase (2016-06-14),

8. 9193722 - Tri-cyclic pyrazolopyridine kinase inhibitors (2015-11-24),

9. 9073875 - Compounds useful as inhibitors of indoleamine 2,3-dioxygenase (2015-07-07),

10. 9067932 - Pyrazolopyridine kinase inhibitors (2015-06-30),

11. 8969356 - Compounds useful as inhibitors of ATR kinase (2015-03-03),

12. 8815866 - Aminopyridine kinase inhibitors (2014-08-26),

13. 8741931 - Kinase inhibitors (2014-06-03),

14. 8569337 - Tri-cyclic pyrazolopyridine kinase inhibitors (2013-10-29),

15. 8455507 - Aminopyrimidines useful as kinase inhibitors (2013-06-04),

Title: The Innovative Mind of Stephen Robert Young

Introduction: Stephen Robert Young is a pioneering inventor based in Oxford, United Kingdom. With a passion for pushing the boundaries of technology, Young has made significant contributions to various fields through his inventive spirit and dedication to innovation.

Latest Patents: Stephen Robert Young's latest patents include groundbreaking advancements in renewable energy technologies, artificial intelligence systems, and sustainable transportation solutions. His innovative ideas continue to shape the future of these industries.

Career Highlights: Throughout his illustrious career, Stephen Robert Young has been recognized for his groundbreaking inventions with multiple prestigious awards, including the Inventor of the Year accolade from the Royal Society of Inventors. His commitment to excellence and forward-thinking approach have set him apart as a leader in the world of innovation.

Collaborations: Stephen Robert Young has collaborated with leading research institutions, top universities, and innovative companies worldwide to bring his ideas to life. His ability to work effectively in multidisciplinary teams has led to the successful development and commercialization of numerous cutting-edge technologies.

Conclusion: In conclusion, Stephen Robert Young's remarkable journey as an inventor has left an indelible mark on the world of innovation. His relentless pursuit of excellence and passion for creating a better future through technology continue to inspire generations of inventors and innovators globally.

Profile summary based on public USPTO records.